The clinical decision support tool has low performance in predicting outcome to ustekinumab in Crohn's disease

被引:0
|
作者
Alsoud, D. [1 ,2 ]
Sabino, J. [1 ,2 ]
Ferrante, M. [1 ,2 ]
Verstockt, B. [1 ,2 ]
Vermeire, S. [1 ,2 ]
机构
[1] Katholieke Univ Leuven, Dept Chron Disease Metab & Ageing, Translat Res Gastrointestinal Disorders, Leuven, Belgium
[2] Univ Hosp Leuven, Dept Gastroenterol & Hepatol, Leuven, Belgium
来源
关键词
D O I
暂无
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
P257
引用
收藏
页码:I298 / I299
页数:2
相关论文
共 50 条
  • [1] Clinical Prediction Model and Decision Support Tool for Ustekinumab in Crohn's Disease
    Dulai, Parambir
    Guizzetti, Leonard
    Ma, Tony
    Jairath, Vipul
    Singh, Siddharth
    Feagan, Brian G.
    Gasink, Christopher
    Pires, Antonio
    Sandborn, William J.
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2019, 114 : S373 - S373
  • [2] Vedolizumab Clinical Decision Support Tool Predicts Efficacy of Vedolizumab But Not Ustekinumab in Refractory Crohn's Disease
    Alric, Hadrien
    Amiot, Aurelien
    Kirchgesner, Julien
    Treton, Xavier
    Allez, Mathieu
    Bouhnik, Yoram
    Beaugerie, Laurent
    Carbonnel, Franck
    Meyer, Antoine
    INFLAMMATORY BOWEL DISEASES, 2022, 28 (02) : 218 - 225
  • [3] Performance Characteristics of a Clinical Decision Support Tool for Disease Complications in Crohn's Disease
    Siegel, Corey A.
    Siegel, Lori S.
    Dubinsky, Marla C.
    Targan, Stephan
    Braun, Jonathan
    Landers, Carol
    Bilsborough, Janine
    Princen, Fred
    Lasch, Karen
    Candela, Ninfa
    McGovern, Dermot P. B.
    Dervieux, Thierry
    CROHNS & COLITIS 360, 2021, 3 (04)
  • [4] Development and Validation of a Clinical Decision Support Tool to Predict Outcomes of ustekinumab Treatment in Patients with Crohn's Disease
    Yao, L.
    Cao, Y.
    Cao, Q.
    JOURNAL OF CROHNS & COLITIS, 2024, 18 : I1191 - I1191
  • [5] Clinical Decision Support Tool for Infliximab in Crohn's Disease
    Dulai, Parambir S.
    Wong, Emily C. L.
    Reinisch, Walter
    Narula, Neeraj
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2022, 20 (05) : E1192 - E1195
  • [6] A Clinical Laboratory Evaluation of Performance Characteristics of a Clinical Decision Support Tool for Disease Complications in Crohn's Disease
    Siegel, Corey A.
    Dubinsky, Marla C.
    Siegel, Lori
    Targan, Stephan
    Braun, Jonathan
    Bilsborough, Janine
    Landers, Carol J.
    Princen, Fred
    Candela, Ninfa M.
    Lasch, Karen
    McGovern, Dermot
    Dervieux, Thierry
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2020, 115 : S442 - S442
  • [7] Feasibility of a Clinical Decision Support Tool for Ustekinumab to Predict Clinical Remission and Relapse in Patients With Crohn's Disease: A Multicenter Observational Study
    Park, Jihye
    Chun, Jaeyoung
    Yoon, Hyuk
    Cheon, Jae Hee
    INFLAMMATORY BOWEL DISEASES, 2023, 29 (04) : 548 - 554
  • [8] Specificity of clinical decision support tools for vedolizumab and ustekinumab in biologically naive patients with Crohn's disease
    Kim, Ji Eun
    Won, Hojeong
    Kim, Young-Ho
    Kim, Eun Ran
    Hong, Sung Noh
    Chang, Dong Kyung
    SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 2022, 57 (04) : 446 - 448
  • [9] Clinical decision support tool guided selective intensive induction strategy of ustekinumab in patients with Crohn's disease: real-world evidence
    Li, Q.
    Tang, J.
    Shi, L.
    Lv, X.
    Chen, W.
    Guo, Q.
    Li, M.
    Gao, X.
    Chao, K.
    JOURNAL OF CROHNS & COLITIS, 2024, 18 : I1060 - I1062
  • [10] Clinical utility of ustekinumab in Crohn's disease
    Kotze, Paulo Gustavo
    Ma, Christopher
    Almutairdi, Abdulelah
    Panaccione, Remo
    JOURNAL OF INFLAMMATION RESEARCH, 2018, 11 : 35 - 47